- Home
- MMLP vs EPRX Comparison
MMLP vs EPRX Comparison
Compare MMLP & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMLP
- EPRX
- Stock Information
- Founded
- MMLP 2002
- EPRX 2011
- Country
- MMLP United States
- EPRX Canada
- Employees
- MMLP N/A
- EPRX N/A
- Industry
- MMLP Oil Refining/Marketing
- EPRX
- Sector
- MMLP Energy
- EPRX
- Exchange
- MMLP Nasdaq
- EPRX NYSE
- Market Cap
- MMLP 139.6M
- EPRX 130.0M
- IPO Year
- MMLP 2002
- EPRX N/A
- Fundamental
- Price
- MMLP $3.55
- EPRX $3.28
- Analyst Decision
- MMLP
- EPRX Strong Buy
- Analyst Count
- MMLP 0
- EPRX 1
- Target Price
- MMLP N/A
- EPRX $9.00
- AVG Volume (30 Days)
- MMLP 116.4K
- EPRX 11.9K
- Earning Date
- MMLP 04-16-2025
- EPRX 05-07-2025
- Dividend Yield
- MMLP 0.56%
- EPRX N/A
- EPS Growth
- MMLP N/A
- EPRX N/A
- EPS
- MMLP N/A
- EPRX N/A
- Revenue
- MMLP $707,622,000.00
- EPRX N/A
- Revenue This Year
- MMLP $4.19
- EPRX N/A
- Revenue Next Year
- MMLP N/A
- EPRX N/A
- P/E Ratio
- MMLP N/A
- EPRX N/A
- Revenue Growth
- MMLP N/A
- EPRX N/A
- 52 Week Low
- MMLP $2.36
- EPRX $2.20
- 52 Week High
- MMLP $4.13
- EPRX $4.48
- Technical
- Relative Strength Index (RSI)
- MMLP 41.92
- EPRX N/A
- Support Level
- MMLP $3.44
- EPRX N/A
- Resistance Level
- MMLP $3.74
- EPRX N/A
- Average True Range (ATR)
- MMLP 0.18
- EPRX 0.00
- MACD
- MMLP -0.02
- EPRX 0.00
- Stochastic Oscillator
- MMLP 23.91
- EPRX 0.00
About MMLP Martin Midstream Partners L.P. Limited Partnership
Martin Midstream Partners LP has a diverse set of operations focused in the United States Gulf Coast region. The company's business lines include terminalling, processing, storage, and packaging services for petroleum products and by-products including the refining of naphthenic crude oil; land and marine transportation services for petroleum products and by-products, chemicals, and specialty products; sulfur and sulfur-based products processing, manufacturing, marketing and distribution; and natural gas liquids marketing, distribution and transportation services. Company operates in four segment Terminalling and storage, Transportation, Sulfur service and Specialty products segment. Majority of the revenue derived from Specialty products segment.
About EPRX EUPRAXIA PHARMACEUTICALS INC
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.